Michael Barbella, Managing Editor04.01.23
Enabling technologies and artificial intelligence were the flavors of the week on ODT's website.
In the final days of March, cybervisitors most favored an exclusive account about the benefits of enabling technologies in spine surgery. "Organizations should focus on developing enabling technologies that improve a workflow without disrupting it or requiring a surgeon to change their entire approach in order to accommodate new technology. New technologies should allow a surgeon to defer to the technique and workflow that they tailor to the patient and their unique condition, not the needs of the device," Tommy Carls, vice president of Product Development and Marketing at Proprio, wrote in an online post for ODT. "...the future of differentiation is an enabling technology that works with a variety of implants and fills a unique need, providing real-time information during surgery. While I think that could be threatening or disruptive to implant companies that are still operating in the 1990s era of spine technology development, I believe it is a strong path forward for our industry."
Another strong path forward for the orthopedic industry—artificial intelligence—drove much of the site traffic this past week, as new software from Exactech and AI-based virtual scribe technology both amassed significant page views.
Exactech's new software from Advata extends the capabilities of its machine learning (ML)-based Predict+ clinical decision support tool. The software will further facilitate Predict+ integration with the Equinoxe planning app and encourage integration with other software and databases. Predict+ is a data-driven, clinical decision support tool and the first software of its type to use ML to create personalized risk-benefit analyses to predict outcomes after shoulder replacement surgery. The software was engineered to better inform surgeons on expected outcomes that can be achieved after shoulder arthroplasty, based on clinical experience documented in a single-shoulder prosthesis outcomes database of more than 15,000 patients.
Researchers, meanwhile, are turning to AI to help reduce physician burnout. A new study presented earlier this month at the 2023 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting analyzed the use of documentation modalities including artificial intelligence (AI)-based virtual scribe services to determine the overall quality and time it takes to capture a patient encounter. While AI proved to be a promising tool, some verification and correction is necessary for accuracy.
Other items of interest to cybervisitors included the first use of Stryker Corp.'s Tornier pyrocarbon humeral head, and Miach Orthopaedics' new sales and marketing vice president.
In the final days of March, cybervisitors most favored an exclusive account about the benefits of enabling technologies in spine surgery. "Organizations should focus on developing enabling technologies that improve a workflow without disrupting it or requiring a surgeon to change their entire approach in order to accommodate new technology. New technologies should allow a surgeon to defer to the technique and workflow that they tailor to the patient and their unique condition, not the needs of the device," Tommy Carls, vice president of Product Development and Marketing at Proprio, wrote in an online post for ODT. "...the future of differentiation is an enabling technology that works with a variety of implants and fills a unique need, providing real-time information during surgery. While I think that could be threatening or disruptive to implant companies that are still operating in the 1990s era of spine technology development, I believe it is a strong path forward for our industry."
Another strong path forward for the orthopedic industry—artificial intelligence—drove much of the site traffic this past week, as new software from Exactech and AI-based virtual scribe technology both amassed significant page views.
Exactech's new software from Advata extends the capabilities of its machine learning (ML)-based Predict+ clinical decision support tool. The software will further facilitate Predict+ integration with the Equinoxe planning app and encourage integration with other software and databases. Predict+ is a data-driven, clinical decision support tool and the first software of its type to use ML to create personalized risk-benefit analyses to predict outcomes after shoulder replacement surgery. The software was engineered to better inform surgeons on expected outcomes that can be achieved after shoulder arthroplasty, based on clinical experience documented in a single-shoulder prosthesis outcomes database of more than 15,000 patients.
Researchers, meanwhile, are turning to AI to help reduce physician burnout. A new study presented earlier this month at the 2023 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting analyzed the use of documentation modalities including artificial intelligence (AI)-based virtual scribe services to determine the overall quality and time it takes to capture a patient encounter. While AI proved to be a promising tool, some verification and correction is necessary for accuracy.
Other items of interest to cybervisitors included the first use of Stryker Corp.'s Tornier pyrocarbon humeral head, and Miach Orthopaedics' new sales and marketing vice president.
